FNBT
ALIM

FineMark National Bank & Trust’s Alimera Sciences ALIM Stock Holding History

FineMark National Bank & Trust’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,480
Closed -$49K – 1503
2015
Q3 		$49K Sell
1,480
-667
-31% -$37.6K 0.01% 630
2015
Q2 		$148K Hold
2,147
– – 0.02% 395
2015
Q1 		$161K Buy
2,147
+67
+3% +$5.27K 0.02% 388
2014
Q4 		$173K Sell
2,080
-1,644
-44% -$133K 0.03% 375
2014
Q3 		$303K Buy
3,724
+667
+22% +$57K 0.05% 265
2014
Q2 		$274K Hold
3,057
– – 0.05% 282
2014
Q1 		$362K Hold
3,057
– – 0.07% 228
2013
Q4 		$216K Sell
3,057
-3,000
-50% -$122K 0.04% 296
2013
Q3 		$342K Hold
6,057
– – 0.08% 209
2013
Q2 		$443K Buy
+6,057
New +$350K 0.13% 140

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FineMark National Bank & Trust's ALIM Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Alimera Sciences (ALIM) in Q4 2015, closing a stake of 1,480 shares — an estimated $49K sold.

FineMark National Bank & Trust first reported a position in ALIM in Q2 2013 and held it in 10 quarters. The position peaked at $443K in Q2 2013. 66 funds tracked by Wall St. Rank hold ALIM as of Q4 2015.

  • FineMark National Bank & Trust reported no remaining Alimera Sciences position as of Q4 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 1,480 Alimera Sciences shares in Q4 2015, an estimated $49K.
  • FineMark National Bank & Trust first reported a position in Alimera Sciences in Q2 2013 and held it in 10 quarters.
  • FineMark National Bank & Trust's Alimera Sciences position peaked at $443K in Q2 2013.
  • 66 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.